ChemRar, Lancet partner to develop and commercialize new medications in Russia ChemRar High Tech Center , the Russian pharmaceutical R&D and purchase group, and Lancet, Russian Distribution Company, have announced collaboration for research, development and commercialization of new medicines in Russia with the intention to stimulate the innovative development of the Russian pharmaceutical industry common info . Through the partnership ChemRar and Lancet plan to develop and produce new drugs in major therapeutic areas which are a high priority for the Russian Federation healthcare system according to the significant Government strategy PHARMA-2020. The parties have agreed to co-spend in the additional development of creation capacities in order to localize the pharmaceutical creation in the Russian Federation.
Chitosan is commercially extracted from the shells of crustaceans and is used as a preservative in foods in a number of countries, but not in Norway until recently. Even though its capability to inhibit bacterial development was already described, there are few studies linked to chitosan’s different chemical substance characteristics. Her research also implies that the growth of activated spores of the Bacillus cereus, which in turn causes food poisoning, could possibly be inhibited by applying different types of chitosans. The substance may possess potential as an additive to foodstuffs therefore, with a look at to preventing the growth of B.